The plasmid pBWH77, originally found in an isolate of KlebsieUa pneumoniae, harbors a new antibiotic resistance operon containing two resistance genes transcribed from an IS26-hybrid promoter, as shown by nucleotide sequencing, mRNA mapping, and the effect of inserting a transcription terminator within the promoter-proximal gene. The nucleotide sequence of this region revealed that the operon (IAB) is made up of three sections that are closely related to previously described genetic elements. The -35 region of the promoter, together with the adjacent sequence, is identical to sequences of the IS26 element. One of the resistance genes, aphA7, which is located next to the hybrid promoter, confers assistance to neomycin and structurally related aminoglycosides. This aphA7 gene is highly homologous to aphAl of Tn903, with five nucleotide differences. The second gene, blaS2A, encodes an evolved SHV-type ,-lactamase with a pI of 7.6 that confers resistance to the broad-spectrum cephalosporins cefotaxime and ceftizoxime. The deduced amino acid sequence of shows that amino acid 238 is a serine, a residue reported to confer resistance to cefotaxime. We discuss how the operon may have evolved by a combination of insertion sequence-mediated genetic rearrangements and acquisitive evolution. Using phylogenetic parsimony, we show that aphA7 in the LAB operon evolved from an ancestral form similar to aphAl in Tn903 and that blaS2A evolved from an ancestral form similar to blaSI.
Insertion sequences (ISs) are widely distributed on bacterial chromosomes and plasmids even though they only encode the gene products needed for their own transposition. As these ISs are frequently associated with unstable genetic traits, it has been suggested that they are sustained by direct selection acting on genetic versatility (9, 22, 30) , either through enhancing mobility or through inducing beneficial regulatory mutations. This selectionist hypothesis (35) is an alternative to the hypothesis that ISs are parasitic or selfish (10, 27) . The best evidence in favor of the selectionist hypothesis has been the close linkage between insertion sequences and plasmid-borne antibiotic resistance genes, often in the form of complex transposons. This linkage provides correlative evidence that ISs have been involved in either the evolution or the dissemination of these antibiotic resistance genes.
In this report, we present evidence that IS26 has recently been involved in the assembly of a new antibiotic resistance operon (IAB) and show that this insertion element provides part of the promoter of this operon. IS26 has been associated with several antibiotic resistance genes, including aphAl in Tn2680 and other transposons (20) and a blaT-aacC5 operon in the plasmid pUZ3644 (17) , and has been assumed from sequencing data to provide part of a hybrid promoter for aacC genes in the plasmids pWP7b and pWP14a (7) . In addition, Prentki et al. (29) suggested that IS26 is a portable -35 promoter site.
The IAB operon contains the aphA7 gene encoding . The second gene of the IAB operon is blaS2A, which encodes a ,-lactamase (SHV-2A) that hydrolyzes the new broad-spectrum cephalosporin cefotaxime, whereas the ancestral blaSi gene encodes a 3-lactamase (SHV-1) that is MATERIALS AND METHODS Bacterial strains and plasmids. Bacterial strains and plasmids used in this study are described in Table 1 . The 150-kilobase (kb) plasmid pBWH77 (13) was transferred from Klebsiella pneumoniae 5214773 into an Escherichia coli K-12 strain (SY203) by conjugation (19) . The chimeric plasmid pJH194 was constructed by subcloning a BamHI fragment of pBWH77 into the vector pACYC184 to give pJH194, a plasmid with a 12.5-kb fragment from pBWH77 that conferred resistance to neomycin and cefotaxime. Deletion of a Sall fragment in pJH194 reduced the size of the pBWH77 DNA to 3.5 kb, to give the plasmid pJH196 (Fig.  1 ). This plasmid also conferred resistance to cefotaxime and neomycin.
Chemicals and reagents. Cefotaxime was a gift from Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. Other antibiotics were purchased from Sigma Chemical Co., St. Louis, Mo. Restriction endonucleases, nuclease Bal 31, T4 DNA ligase, and T7 DNA polymerase were purchased from New England BioLabs, Inc., Beverly, Mass. DNase I was purchased from Boehringer Mannheim Biochemicals, Indianapolis, Ind. The DNA-sequencing kit was purchased from U.S. Biochemical Corp., Cleveland, Ohio, and
[32P]dATP was from Amersham Corp., Arlington Heights, Ill. All enzymes were used according to the specifications of the manufacturers.
Construction and preparation of plasmid subclones. Endonuclease digestion, cloning, and transformation procedures were done by the methods of Maniatis et al. (16) . Plasmid DNA was prepared by the method of Birnboim and Doly (5).
Isoelectric focusing. Isoelectric focusing analysis of SHV-2A was kindly performed by A. Mederios, using the technique of Matthew et al. (18) . This study M13 subcloning and nucleotide sequencing. Deletion derivatives of pJH196 were constructed by Bal 31 deletion from the Sall and BamHI sites, followed by ligation with Sall and BamHI linkers. The resulting short segments of pBWH77-derived DNA were subcloned into the polylinker of the replicative forms of bacteriophage M13 derivatives mpl8 and mpl9 (38) . E. coli JM101 (24) was transfected with the recombinant phage. Additional deletions were obtained by digestion of M13 subclones with DNase I-Mn2+. Also, five 17-base oligonucleotides were synthesized to provide an overlapping set of sequencing primers. Nucleotide sequences were determined by the dideoxynucleotide-chain termination method (32) with [Ca-32P]dATP. The nucleotidesequencing strategy is shown in Fig. 1 . DNA fragments were resolved by electrophoresis on vertical 6% polyacrylamide gels (80 cm by 21 cm by 0.4 mm) containing 8 M urea. After drying, the gels were autoradiographed with Kodak X-OMAT film. The complete DNA sequence was arranged by using the software package of Hitachi America Ltd.
Si protection assay. Total RNA was extracted from E. coli Insertion of transcription terminator into aphA7. The 600-base-pair (bp) XhoI-SmaI fragment from pET112 that contains the Ti and T2 rRNA transcription terminator sequence of rrnB (6) was inserted into the XhoI-SmaI site in aphA7 by digesting the two plasmids with XhoI and SmaI and then ligating the mix of fragments. E. coli SY203 was transformed with this recombinant DNA, selecting for chloramphenicol resistance. Resistant colonies were screened for kanamycin sensitivity and their cefotaxime phenotype.
RESULTS
Genes encoding neomycin and cefotaxime resistance are closely linked in pBWH77. The 150-kb plasmid pBWH77, isolated in a cefotaxime-resistant strain of K. pneumoniae (13) , encodes resistance to ampicillin, cefotaxime, neomycin, gentamicin, streptomycin, amikacin, tobramycin, chloramphenicol, trimethoprim, and sulfonamide. Earlier work (15) suggested that plasmid-bome resistance to the broadspectrum cephalosporin cefotaxime is due to the presence of an evolved ,3-lactamase. Because of our interest in understanding mechanisms of acquisitive evolution, we cloned the cefotaxime resistance gene from pBWH77 (see Materials and Methods) and in doing so found that the cefotaxime and neomycin determinants were closely linked.
The neomycin resistance gene located on pJH196 is aphA7, which encodes an aminoglycoside-3',5"-phosphotransferase-I. This enzyme inactivates neomycin, kanamycin, paramomycin, lividomycin, and G418 (Lee et al., submitted). The cefotaxime resistance gene is blaS2A, which encodes the SHV-2A 1-lactamase. This ,B-lactamase is designated an SHV enzyme on the basis of its isoelectric point of 7.6 and its sequence (see below). Antibiotic susceptibility testing showed that SHV-2A also conferred resistance to ceftizoxime and ceftriazone but not to ceftazidime or the monobactam moxalactam (data not shown).
Nucleotide sequence of IS26-aphA7-blaS2A region. The complete nucleotide sequence of the IAB operon was determined ( Fig. 2) . The first 343 nucleotides from the Sall site are nearly identical to sequences from IS26, including the 14-bp terminal inverted repeat sequence (IRS) (21) . Sequences homologous to Tn9O3 begin immediately past the outside base of the IRS. Although we did not determine the sequence to the left of the SalI site, a complete IS26 appears to be present in pJH194 based on the presence of characteristic restriction sites. The coding sequence of aphA7 begins at nucleotide 410 and extends to 1222. This sequence is closely related to aphAl of Tn9O3 (K.-Y. Lee et al., unpublished data). The blaS2A sequence extends from base 1281 to base 2138 and differs by 11 bases from the sequence of blaSlA while being identical to a previously described blaS2 allele (R. C. Levesque, personal communication). In this report, we are using the amino acid sequences deduced from the nucleotide sequences. here, we designate the Levesque sequences as SHV-1A and blaSIA. The 58 bases between the translation termination codon of aphA7 and the translation start codon of blaS2A, as well as bases 2139 to 2375, have a high degree of homology with the sequences flanking the K. pneumoniae chromosomal ,-lactamase gene len-i (1), whose product is known to be closely related to the SHY-1 P-lactamase (2) segment of DNA that is apparently the -35 (TTGTGA) and -10 (TATTCT) regions of len-i and blaSIA.
These suggestions of the promoter organization were supported by direct physical mapping of the 5' end of the mRNA by using an S1 endonuclease protection assay and two DNA probes. Probe 1, the HindIII-BalI fragment (Fig.  1) , would hybridize to mRNA from the 3' end of aphA7 and the 5' end of blaS2A, while probe 2, the SalI-XhoI fragment, would hybridize to RNA originating from the 5' end of the aphA7 gene and the IS26 sequence. With probe 1, the assay gave a single fragment protected from Si endonuclease digestion corresponding to the full length of the probe (Fig.  3A) . This band is presumably a mixture of DNA-iRNA hybrids and reannealed DNA-DNA molecules. No shorter fragments were evident, indicating that there is no shorter transcript initiated from a promoter between aphA7 and blaS2A. Using probe 2, we found that the total RNA preparation from SY203(pJH196) would protect a nucleotide fragment 77 nucleotides long (Fig. 3B) . This shows that the 5' end of the message is located in front of the aphA7 gene at nucleotide 367; this is the expected transcript originating from the identified IS26-hybrid promoter. The larger fragment in Fig. 3B To establish more thoroughly that a second promoter was not present between aphA7 and blaS2A, we inserted a transcription terminator sequence into the aphA7 gete and showed that this abolished expression of both the aphA7 and blaS2A gen-es. In this experiment, we inserted a 600-bp DNA fragment that included the E. coli T1-T2 terminator sequence of rrnB (6) into the XhoI-SmaI site of pJH196 (Fig. 1) and examined the phenotype conferred on E. coli SY203 by the resulting plasmid, pKL250. Twenty-five chloramphenicolresistant, kanamycin-sensitive transformants were analyzed. Twenty-four of these were found to be cefotaxime sensitive, while one showed a low level of cefotaxime resistance. Restriction analysis of the kanamycin-sensitive, cefotaximesensitive plasmids confirmed that the terminator sequence was properly inserted into the XhoI-SmaI site of the aphA7 gene. This shows that transcription of blaS2A requires sequences to the left of the XhoI site located in aphA7.
Finally, we measured the in vivo primary transcript of the aphA7 and blaS2A genes by performing a Northern (RNA) assay (Fig. 4) . In this assay, total RNA was fractionated on an agarose gel and the gel was probed with two DNA fragments, the SalI-XhoI fragment and a synthetic oligonucleotide extending from nucleotides 1362 to 1347. Both probes showed the presence of a 1.7-kb transcript consistent with an mRNA beginning at position 367 and continuing to 2134. Other transcripts are evident, with both probes indicating a shorter transcript with the same 5' end as the 1.7-kb transcript. This shorter transcript may result from a weak transcription terminator within the operon or from nuclease digestion from the 3' end of the longer transcript. Therefore, we conclude that aphA7 and blaS2A constitute a single transcriptional unit.
Evolution of blaS2A. The above results establish that aphA7 and blaS2A form the IAB operon and that the a_.. promoter is, in part, provided by IS26. We would like to argue further that IAB has been assembled from ancestral forms of an aphA gene and a blaS gene that were initially unlinked to each other. First consider blaS. This argument uses the principle of parsimony in phylogenetic reconstruction and relies on comparing blaSIA and blaS2A with len-i as an outgroup taxon. The SHV 1-lactamases are closely related to the K. pneumoniae chromosomally encoded LEN-1 3-lactamase (1). The evolutionary distances between blaSIA and len-i and between blaS2A and len-i are 0.11 and 0.11, respectively. (The evolutionary distance is the number of sites that are different divided by the number of sites that are being compared over the region of homology.) Moreover, the relationship between these three genes is preserved in both the 5' and 3' sequences flanking blaSIA, blaS2A, and len-i as is apparent from the sequences in Fig. 2 . Therefore, these flanking sequences must have been present in the common ancestor to these three genes, which is designated as node X in Fig. 5 . Because blaSiA and blaS2A are much more closely related to each other than they are to len-i, we can assign a common ancestor to them that excludes len-i, which is designated node Y in Fig. 5 . Furthermore, we can say that the ancestral configuration at node Y is blaSIA-like rather than blaS2A-like. This follows because the blaSI gene shares at least 36 bp with len-i, upstream of the coding sequence and including the promoter, that are not present in blaS2A. In this scheme, those common sequences were deleted after divergence at node Y in the lineage leading to blaS2A. In assigning a blaSIA-like ancestral state to node Y, we are assuming that a deletion of the 36 nucleotides in the branch leading to blaS2A is much more probable than is the independent insertion of those same sequences in the independent branches leading to len-i and blaSIA. Therefore, we can conclude with a very high level of confidence that blaS2A evolved from a biaSIA-like ancestor.
The tree in Fig. 5 and the assignment of the ancestral nodes is based on the presence or absence of 5'-and 3'"flanking sequences and on the number of nucleotide differences between the homologous segments by using parsimony in phylogenetic reconstruction. Using a historical argument, we can also conclude that blaS2A probably evolved from a blaSIA-like ancestor. It appears that SHV-2A evolved from a SHV-1-like ancestor under the selective pressure of cefotaxime use. The SHV-1 1-lactamase was repeatedly isolated from penicillin-and carbenicillin-resistant bacteria before the introduction of the new broadspectrum cephalosporins such as cefotaxime (25 
DISCUSSION
We established that the plasmid pBWH77 carries an operon (IAB) composed of the aminoglycoside resistance gene aphA7 and the 13-lactamase resistance gene blaS2A. We showed that this operon is under the control of an efficient hybrid promoter, part of which consists of the IRS of an IS26 element. The close association of ISs with antibiotic resistance genes has strongly suggested an active role for these sequences in the evolution or mobility of antibiotic resistance genes. The structure and sequence of the IAB operon allow us to strengthen this hypothesis. This follows because the three elements that make up IAB have all been encountered previously in entirely different contexts, and furthermore, we can infer that IAB evolved from these previously described elements. Thus, for example, we were able to establish the direction of descent of blaS2A through the application of phylogenetic tree construction principles and through the availability of sufficient sequence information to allow us to root our tree to a convenient outgroup, the K.
pneumoniae len-i P-lactamase. Using sitilar arguments, we have also shown that aphA7 evolved from an aphA gene that has been seen in Tn9O3 and Tn2350 (Lee et al., submitted).
Pairs of resistance genes forming a single operon have been reported before (7, 12, 17, 23 differences between IAB and its individual parts have been selected. The blaS2A gene encodes an enzyme that has a Ser-238 compared with the Gly-238 of its assumed ancestor, SHV-1, a change that increases affinity of the enzyme for certain third-generation cephalosporins, so that the gene confers resistance to cefotaxime and ceftizoxime. In addition, the aphA7 gene encodes an enzyme that has four amino acid differences from its assumed ancestor, aphAl, changes that appear to be a consequence of aquisitive evolution (Lee et al., submitted). Presumably, the creation of a hybrid promoter with the -35 region provided by IS26 was selected. Both aphAl in Tn903 and aphA7 have efficient promoters, but cells containing the latter gene have 2.4-fold as much aminoglycoside-3',5"-phosphotransferase-I as cells containing Tn903 (Lee et al., submitted), suggesting that the IS26 insertion has produced a more efficient promoter. This more efficient promoter could be adaptively significant, either from more gene product, or possibly, the ancestral promoter found in Tn903 may have been inadequate to drive transcription of the two-gene operon.
The actual steps in the evolution of the IAB operon from the ancestral blaS and aphA genes and IS26 cannot be reconstructed, but it is possible to describe two possible pathways based on our knowledge of several aphAl transposons. One pathway would begin with the insertion of Tn903 upstream of a blaSJ-like gene, followed by an insertion of IS26 between one of the IS903s and the 5' end of the aphAl gene and a deletion extending from the 3' end of the aphAl gene to 58 bp before the 5' end of the blaS gene. The aphAl gene and the -10 region of Tn903 are identical with those from the IAB operon sequences except for the five nucleotide substitutions within the aphA gene (26; Lee et al., submitted), making Tn903 a strong candidate for the IAB operon precursor. In Tn903, the -35 region of the aphAl promoter is provided by sequences outside of the IS element (26) . Tn4352 is a possible intermediate in this pathway. It has the aphAl gene and the -10 and -35 promoter sequences as in Tn903, but with an IS26 located immediately beyond the -35 region (37) . A small deletion event within Tn4352 would generate the hybrid promoter structure of the IAB operon (Fig. 6) .
A second possible pathway is suggested by the transposon Tn2680, which has IS903 and IS26 sequences in close proximity, with the aphAl gene adjacent to an IS903 variant and IS26 elements forming the ends of the transposon (20) . An internal inversion event in Tn2680 would place the aphAl gene under the control of a hybrid IS26-Tn903 promoter, with the IS26 in the same orientation as the IAB operon. A second step would be the insertion of this transposon next to a blaS gene, followed by deletion of the sequences between the aphASI and blaS genes. However, the nucleotide sequence of the Tn2680 aphAl gene and its promoter-proximal flanking region show significant divergence from Tn903 and the IAB operon, so Tn2680 is only suggestive of the possible structure of an IAB precursor.
Both of the genes in the IAB operon appear to have undergone recent adaptive evolution. Examples of adaptive evolution are exceedingly rare in molecular evolution, as the vast majority of cases involve neutral substitutions. Four cases of adaptive evolution can be cited: (i) the cefotaximehydrolyzing P-lactamases (33) , (ii) aphA7, (iii) the convergent substitutions seen with the ruminant and leaf-eating primate lysozymes (34) , and (iv) the G protein (39) . It could be just a coincidence that two of these unusual cases have been encountered in this single operon. It is difficult to imagine an evolutionary mechanism to account for this, two genes under independent selective pressure becoming linked as a result, although it is certainly tempting to speculate along such lines. 
